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http://dx.doi.org/10.1016/j.stemcr.2016.11.014SUMMARYLoss-of-function mutations in the cytosine-5 RNA methylase NSUN2 cause neurodevelopmental disorders in humans, yet the underlying
cellular processes leading to the symptoms that includemicrocephaly remainunclear.Here,we showthatNSUN2 is expressed in earlyneuro-
epithelialprogenitorsof thedevelopinghumanbrain,andits expression isgradually reducedduringdifferentiationofhumanneuroepithelial
stem (NES) cells in vitro. In the developingNsun2/ mouse cerebral cortex, intermediate progenitors accumulate and upper-layer neurons
decrease.LossofNSUN2-mediatedmethylationof tRNA increases their endonucleolytic cleavagebyangiogenin, and50 tRNAfragmentsaccu-
mulate in Nsun2/ brains. Neural differentiation of NES cells is impaired by both NSUN2 depletion and the presence of angiogenin. Since
repression of NSUN2 also inhibited neural cell migration toward the chemoattractant fibroblast growth factor 2, we conclude that the
impaired differentiation capacity in the absence of NSUN2 may be driven by the inability to efficiently respond to growth factors.INTRODUCTION
Human brain development begins with the differentiation
of neural progenitor cells in the third gestational week and
extends through to adolescence (Stiles and Jernigan, 2010).
The first cells committed to a neural fate appear during
gastrulation in a single sheet of cells with epithelial features
(Stern, 2005). These neuroepithelial stem (NES) cells then
differentiate further into multiple types of cells, including
neurons, astrocytes, and other glial cells (Temple, 2001).
The brain is the most complex organ and its formation re-
quires a tight control of lineage-specific differentiation
pathways. To date many transcriptional networks have
been identified as important regulators of lineage specifica-
tion, yet little is known about the function of posttran-
scriptional regulation in the developing brain.
Gene expression is dynamically controlled through
reversible chemical modifications in DNA and histones
(Bannister and Kouzarides, 2011; Deaton and Bird, 2011).
Covalent modifications are also commonly found in
RNA, but their precise role in regulating gene expression
and translation remains less well understood. However,
RNA modifications are crucial for development and aber-
rant deposition of RNA modifications can lead to complex
human diseases, including neurodevelopmental disorders
and cancer (Frye and Blanco, 2016; Popis et al., 2016).
Many of the more than 100 known chemical modifica-
tions found in RNA have been described decades ago
(Machnicka et al., 2013), but their potentially very broad112 Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017 j ª 2017 The Au
This is an open access article under the CC BY license (http://creativecommoroles in regulating RNAmetabolism emerged only recently.
Novel transcriptome-wide approaches revealed vital roles
for pseudouridine, N6-methyladenosine, N1-methyladeno-
sine, and 5-methylcytosine (m5C) in posttranscriptional
gene regulation (Carlile et al., 2014; Dominissini et al.,
2012, 2016; Hussain et al., 2013a; Khoddami and Cairns,
2013; Lovejoy et al., 2014; Meyer et al., 2012; Schwartz
et al., 2014).
Cytosine-5 methylation in RNA is mediated by a large
protein family of conserved RNA:m5C-methyltransferases
(Motorin et al., 2010). NSUN2 is onemember of this family
andmethylates the vastmajority of tRNAs as well as a small
number of other non-coding (ncRNAs) and coding RNAs
(cRNAs) (Blanco et al., 2014; Hussain et al., 2013a; Khod-
dami and Cairns, 2013). Loss of NSUN2-mediated methyl-
ation of tRNAs increases their affinity to the endonuclease
angiogenin, resulting in increased cleavage of tRNAs and
accumulation of 50 tRNA fragments (Blanco et al., 2014,
2016). The function of tRNA-derived ncRNA fragments is
to repress global protein translation (Gebetsberger et al.,
2012; Ivanov et al., 2011).
The correct deposition of m5C into RNAs is essential for
normal development. Loss-of-function mutations in the
NSUN2 gene in bothmouse and human cause growth retar-
dation and neurodevelopmental deficits including micro-
cephaly, as well as defects in cognition andmotor function
(Blanco and Frye, 2014). In the developing mouse brain,
expression of NSUN2 is highest in the cerebral cortex,
hippocampus, and striatum, and all of these areas showthors.
ns.org/licenses/by/4.0/).
Figure 1. Expression of NSUN2 in the Human Developing Brain
and NES Cells
(A) DAPI-stained human embryo (6 weeks of gestation) marked for
prosencephalon, mesencephalon, and rhombencephalon. Region in
square is magnified in (B). Scale bar, 1 mm.
(B) Prosencephalon labeled for NSUN2 and SOX1. Region in squares
are magnified in (b0) and (b00). Arrows indicate NSUN2-positive
cells. Scale bar, 100 mm.
(C–F) Bright-field image (C) and immunofluorescence (D–F) of AF22
(upper panels) and Sai1 (lower panels) cells labeled for Nestin (D),
SOX2 (E), and bIII-tubulin (F). Scale bar, 50 mm.
(G and H) NES cells co-labeled for NSUN2 and Nestin (NES) (G) or
SOX1 (H).
(I) Differentiation protocol.decreased global protein synthesis, increased cellular stress,
and reduction in size in the absence ofNsun2 (Blanco et al.,
2014). Importantly, cleaved 50 tRNA fragments are required
and sufficient to induce the cellular stress responses, and
both cellular stress and microcephaly can be rescued
through inhibition of angiogenin (Blanco et al., 2014).
Here, we set out to dissect the underlying cellular pro-
cess leading to the selective reduction in size of the cere-
bral cortex in the absence of NSUN2. In the developing
mouse brain, deletion of Nsun2 does not affect radial glia
but delays differentiation into upper-layer neurons. In hu-
mans, NSUN2 is expressed in early neuroepithelial progen-
itors during development and cultured neuroepithelial
stem/progenitor cells. Repression of NSUN2 is sufficient
to inhibit neural migration and, in the presence of angio-
genin, impairs neural lineage commitment. Thus, cyto-
sine-5 RNA methylation pathways are required for the
efficient cellular response toward neural lineage-inductive
stimuli.RESULTS
NSUN2 Is Expressed in Stem and Progenitor Cells
during Human Brain Development
To detect NSUN2 in early human brain development, we
performed immunohistochemistry on sagittal sections
from 6-week-old embryos (Carnegie stage 16) (Figures 1A
and 1B). Nucleolar expression of NSUN2 overlapped
with SOX1, a marker for early neuroepithelial progenitors
in the neural tube (Figures 1A and 1B). Thus, NSUN2 is
expressed in early neuroectodermal cells that are capable
of differentiating into various region-specific neuronal
and glial cell types (Li et al., 2005; Perrier et al., 2004).
To characterize the expression of NSUN2 during human
neural differentiation, we used an NES cell line (Sai1) iso-
lated from embryonic hindbrain (Carnegie stage 15) and
neuroepithelial-like stem cells (AF22) derived frompluripo-
tent cells (Falk et al., 2012; Tailor et al., 2013). In prolifer-
ating conditions, AF22 and Sai1 cells showed the character-
istic ‘‘rosette structures’’ (Figure 1C) (Wilson and Stice,
2006). Both lines expressed high levels of the NES cell
markers Nestin and SOX2 but very low levels of the neural
differentiation marker bIII-tubulin (TUBB3) (Figures 1D–
1F). As expected, NSUN2 co-localized with Nestin and
SOX1 in cultured NES cells (Figures 1G and 1H).(J–L) Differentiated AF22 and Sai1 cells (day 15) labeled for Nestin
(NES; J), SOX2 (K), and bIII-tubulin (L). Scale bars: 50 mm.
(M) Western blot for NSUN2, bIII-tubulin (TUBB3), GFAP, SOX2,
and Nestin during differentiation (days). a-Tubulin served as
loading control.
Nuclei are counterstained with DAPI (A, B, D–F, J–L).
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Figure 2. Reduction of Upper-Layer Neu-
rons in the Nsun2/ Cortex
(A) Mouse brain cortex at E18.5 showing the
location of the indicated markers. Region in
red rectangle is imaged in (B), (C), and (G).
(B and C) E18.5 mouse cortex labeled for
PAX6 (B) and TBR2 (C) in wild-type (left-
hand panels) and Nsun2/ (right-hand
panels) brains. The area between the dashed
lines indicates marker-positive cells.
(D) Average of TBR2-positive (TBR2+) cells
in Nsun2/ (MBKW) and wild-type litter-
mates during development (n = 9 mice; five
sections per data point).
(E and F) Increased thickness (E) and
number (F) of TBR2+ cells was confirmed
in an independent Nsun2/ knockout
line (D014D11). PAX6-positive (PAX6+) cells
were unaffected (E; left-hand panel). Data
are mean ± SD (n = 3 sections from two mice
per genotype). WT, wild-type.
(G) Cortical section of wild-type (WT) and
Nsun2/D014D11 mouse brains at E18.5
labeled for markers for layer VI (TBR1), layer
V (CTIP2), and layer IV (SATB2).
(H) Quantification of (G) showing percent-
age of the indicated populations in the
cortical plate. Data represent mean ± SD
(n = 3 mice per genotype).
Significance was assessed using Student’s
t test. **p < 0.01. Scale bars, 50 mm. See
also Figure S1.Next, we induced differentiation of these cell lines by
removal of the growth factors FGF2 (fibroblast growth fac-
tor 2) and EGF (epidermal growth factor) (Figure 1I). After
15 days in differentiation medium, the culture developed
into complex multicellular aggregates with axonal-like
growth at the periphery that still expressed Nestin and
SOX2 but upregulated bIII-tubulin (Figures 1J–1L). In
differentiation medium, we observed a gradual downregu-
lation of NSUN2 together with Nestin and SOX2, bIII-
tubulin expression was upregulated, and glial fibrillary
acidic protein (GFAP), a marker for astrocytes, was not
detectable (Figure 1M).
We concluded that human NSUN2 is expressed in stem
and progenitor cells during early human brain develop-
ment and downregulated during neural differentiation.
Upper-Layer Neurons Are Decreased in Nsun2
Knockout Brains
Loss-of-function mutations in NSUN2 cause microcephaly
in mouse and human (Blanco et al., 2014; Martinez et al.,
2012). Therefore, we next asked whether the reduction in
brain size might be due to an inadequate production of114 Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017differentiated neurons during neurogenesis (Sun and Hev-
ner, 2014). To visualize neuronal stem cells and their differ-
entiated progeny, we labeled sections of the mouse cortex
at embryonic day 18.5 (E18.5). At this stage of embryonic
development NSUN2 is highly expressed in the cortex, hip-
pocampus, and striatum, and the reduction of size of
Nsun2/ frontal brain lobe areas are most pronounced
(Blanco et al., 2014).
In the brain cortex, stem cell populations (or radial glia)
reside in the ventricular zone and express the transcription
factor PAX6; intermediate progenitors localize to the sub-
ventricular zone and express TBR2 (Figure 2A) (Englund
et al., 2005). While PAX6-positive layers were comparable,
TBR2-positive layers increased in the absence ofNsun2 (Fig-
ures 2B and 2C). The number of TBR2-positive cells was
consistently higher in the Nsun2/ cortex during embry-
onic development (Figure 2D). To confirm our findings,
we measured the thickness of PAX6- and TBR2-postive
layers in a second independent mouse Nsun2 knockout
line (Nsun2D014D11). While similar in PAX6-positive layers,
both layer thickness and number of TBR2-positive cells
increased in the absence of NSUN2 (Figures 2E and 2F).
Next, we assessed the cortical plate, the area of the cortex
to which mature neurons migrate during corticogenesis.
Triple staining for TBR1, CTIP2, and SATB2 mark the
neuronal layers VI, V, and IV–II, respectively (Figure 2A).
Both the thickness and total number of cells in the cortical
plate were reduced inNsun2/ brains (Figures 2G and 2H).
However, only the percentage of the SATB2+ population
was significantly reduced in the Nsun2/ cortical plate
(Figure 2H).
Thus, loss of Nsun2 caused an accumulation of interme-
diate progenitors and a decrease in differentiated upper-
layer neurons in the cortex.
Transfer RNAs Are Hypomethylated and Cleaved in
Nsun2/ Brains
To identify all methylation targets of NSUN2, we per-
formed RNA bisulfite sequencing using the frontal brain
regions from wild-type and Nsun2/ mice at E18.5 (Tables
S1, S2, and S3). The median conversion rate from cytosine
to uracil was >99% in all RNA species and, as expected,
tRNAs showed the overall lowest conversion rate (Fig-
ure 3A) (Blanco et al., 2014; Tuorto et al., 2012). Tran-
scripts with >10% methylation in pooled wild-type sam-
ples showed on average significantly less methylation in
the knockout brains (Figure 3B). However, methylation
differences in coding RNA mostly occurred in transcripts
with low coverage (Figure 3C) and, with the exception of
tRNAs, the total number of m5C sites with methylation
levels >20% was low (Figures 3D–3F). The low coverage
and level in methylation in cRNAs and ncRNAs might
indicate that only a small fraction of transcripts carried
NSUN2-dependent m5C sites. Since we cannot exclude
the possibility that non-tRNA RNAs contributed to the
neurological defects in the mouse, we next asked whether
tRNA hypomethylation was sufficient to explain the
neural differentiation deficit observed in the absence of
NSUN2.
Transfer RNAs lacking NSUN2-mediated methylation
have a higher affinity to angiogenin (Blanco et al., 2014).
Angiogenin cleaves tRNAs into small ncRNAs, causing a
reduction in global protein synthesis (Figure 4A) (Blanco
et al., 2016; Ivanov et al., 2011). To identify tRNA frag-
ments in the absence of NSUN2, we performed small
RNA sequencing using the frontal region of wild-type
and Nsun2/ brains at E13.5 and E18.5. We identified all
differential abundant tRNA-derived small ncRNAs (p <
0.01) (Tables S4 and S5), and grouped them into 50- and
30-derived tRNA fragments (Figure 4B). We detected a
significant enrichment of 50-derived tRNA fragments over
30-derived ncRNAs and other fragments (Figure 4C).
Thus, loss of NSUN2 increased cleavage of unmethylated
tRNAs, leading to the enrichment of 50-derived tRNA frag-
ments during mouse brain development. To confirm thatthe cortical phenotype in Nsun2/ mice (Figures 2A–2H)
was caused by angiogenin-mediated cleavage of tRNAs,
we injected pregnant Nsun2+/ females with the angioge-
nin inhibitor N65828 (Blanco et al., 2014; Kao et al.,
2002). The reduction of the SATB2+ population in the
cortical plate of Nsun2/ mice (Figures 2G and 2H) was
rescued by treatment with the angiogenin inhibitor
(ANGi) (Figures S1A and S1B). Thus, we next askedwhether
angiogenin-mediated tRNA cleavage also affected human
NES cell differentiation.
Angiogenin Reduces NES Cell Differentiation
NES cells were treated with recombinant angiogenin
(rANG) and efficient incorporation of rANGwas confirmed
as early as 1 hr after exposure (Figures 4D and 4E). We also
confirmed that even at high concentrations, rANG did
not affect expression or nucleolar localization of NSUN2
(Figures 4F and 4G).
Next, we transfected undifferentiated NES cells with an
NSUN2 small interfering RNA (siRNA) and exposed the
cells to differentiation medium (Figure 5A). We only
measured a significant reduction of TUBB3 RNA expres-
sion after 8 days of differentiation (Figures 5B and
5C). Treatment of rANG alone only slightly and insignif-
icantly affected TUBB3 RNA expression in the whole cell
population (Figure 5D). Upon removal of EGF and FGF2,
NES cells differentiate asynchronously into TUBB3-posi-
tive neurons, GFAP-positive and S100b-positive astroglial
cells, and rarely into O4-positive cells indicative of the
oligodendrocyte lineage (Tailor et al., 2013). To test a
more homogeneous and pure population for neural dif-
ferentiation, we used flow cytometry for the cell-surface
markers CD24 and NCAM (CD56). In human cells,
CD24high populations occur with the transition from a
mixed neural precursor cell population to the neuronal
lineage, and a double-positive (CD24high/CD56high) popu-
lation is consistent with differentiation toward neuro-
blasts and neurons (Pruszak et al., 2007, 2009; Schmandt
et al., 2005).
To assess the differentiation potential of NES cells in the
absence of NSUN2-methylated RNAs but in the presence of
angiogenin, we simultaneously treated the cells with an
siRNA for NSUN2 and exposed them to rANG (Figure 5E).
Both the NCAM+ population and the double-positive
(NCAM+/CD24+) cell population increased with differenti-
ation (Figures 5F and 5G). However, the proportion of dou-
ble-positive cells was significantly reduced when exposed
to the NSUN2 siRNA or rANG (Figures 5F and 5G). The
strongest inhibitory effect on differentiation occurred in
cells treated with both the NSUN2 siRNA and rANG (Fig-
ure 5G). These data were confirmed using a different
set of NSUN2 siRNAs (Figure S2). Together, these results
suggest that low expression of NSUN2 and exposure toStem Cell Reports j Vol. 8 j 112–124 j January 10, 2017 115
Figure 3. Loss of m5C in RNA of Nsun2/ Brains
(A) Bisulfite conversion rate (cytosine to uracil) in tRNA, non-coding (ncRNA), and coding RNA (cRNA) in wild-type (Nsun2+/+) and
knockout (Nsun2/) brains at E18.5. Box plots show the median and interquartile range from minimum to maximum.
(B) Level of methylation in tRNA, ncRNA and cRNA in wild-type (Nsun2+/+) and Nsun2/ brains (sites with >10% methylation in pooled
wild-type samples).
(C) Correlation of coverage in cRNAs from Nsun2+/+ (WT) versus Nsun2/ (KO) samples. Red dots indicate pooled methylation differ-
ences >5% (WT-KO).
(D) Number of m5C sites in tRNA (upper panel), ncRNA (middle panel), and cRNA (lower panel) with the indicated level of methylation in
Nsun2+/+ (WT; gray) and Nsun2/ (KO; red) brain samples.
(E) Correlation of methylation level in WT and KO samples (sites >10 reads coverage and >15% methylation in WT [mouse 1] versus KO
[mouse 4]).
(F) Examples of NSUN2-targeted ncRNA (snoRNA DQ267102), cRNA (Kcnmb3), and tRNAs (GlyGCC and LysCTT) in Nsun2+/+ (upper panels) and
Nsun2/ (lower panels) brains represented as heatmaps. Red, methylated cytosines; gray, unmethylated cytosines; x axis, cytosines;
y axis, reads.
Data are averaged/pooled from four mice per genotype (A–D, F).
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Figure 4. tRNA-Derived Small Non-coding RNAs Accumulate in Nsun2/ Brains
(A) Angiogenin-mediated tRNA cleavage in the absence of NSUN2-dependent methylation.
(B) tRNA secondary structure highlighted for 50-derived (blue) and 30-derived (green) small ncRNAs (20–40 nucleotides). 50 tRNA frag-
ments start at position 1–10 and 30 tRNA fragments start after position 30. VL, variable loop; red circle, methylated sites.
(C) Enrichment (log2 fold change [FC]) of 5
0-derived tRNA fragments (blue) compared with 30-derived fragments (green), other fragments
(start at position 11–30; any length <70), and full-length tRNAs (70–100) at E13.5 and E18.5. Box plots: n = 4 mice per genotype. ****p <
0.0001, Mann-Whitney U test.
(D) NES cells incubated with recombinant angiogenin (rANG) for the indicated time points. Arrows indicate angiogenin-positive. Scale bar,
25 mm
(E) Percentage of cells with internalized rANG per image field.
(F) Nucleolar localization (arrows) of NSUN2 in NES cells. Cells are counterstained with DAPI. Scale bar, 25 mm.
(G) Fold change (FC) of mean NSUN2 RNA expression levels in the presence of rANG versus control-treated Sai1 cells at days 0, 4, and 8 after
induction to differentiate (n = 3 experiments per time point).angiogenin have an additive effect in delaying neural
differentiation.
Delay of Neural Differentiation as a Consequence of
Impaired Motility
CD56 is abundantly expressed in the developing and adult
brain and plays a pivotal role in neurogenesis, neuronalmigration, and neurite outgrowth (Edelman, 1986; Edel-
man and Jones, 1998; Grumet et al., 1982; Rutishauser
et al., 1983). Since cortical development entails stem cell
differentiation into neurons and glia as well as migration
to form all functional layers, we asked whether impaired
migration ofNsun2/ cellsmay explain delayed differenti-
ation into upper-layer neurons.Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017 117
Figure 5. NSUN2 and Angiogenin Affect
Neural Stem Cell Differentiation
(A) Transfection of siRNA (NSUN2 and ctr),
time course of NES cell differentiation, and
sample collection.
(B–D) NSUN2 (B) and TUBB3 (C, D) RNA
expression at days 0, 4, and 8 after growth
factor removal in the presence of an NSUN2
siRNA (B and C) or recombinant angiogenin
(rANG) (D). Shown is DDCt relative to
GAPDH. Error bars denote SD (n = 3 trans-
fections per time point).
(E) Treatment with rANG, the siRNAs for
NSUN2, or a scrambled RNA as control (Ctrl),
and time course of NES cell differentiation.
(F) Flow cytometry for NCAM and CD24 in
control cells and cells treated with rANG and
siRNAs (siNSUN2 or siCtrl) at day 0 (left-
hand panels) and day 8 (right-hand panels)
of the differentiation protocol.
(G) Quantification of cells shown in (F).
n = 5 experiments per condition. Error bars
denote SD. ***p < 0.001, Student’s t test.
See also Figure S2.We transfected Sai1 and AF22 cells with siRNA constructs
for NSUN2 or scrambled RNA as control (Figure 6A) and
plated 10,000 cells into Boyden chambers separated by a
porous membrane from medium lacking or containing
FGF2 as a chemoattractant (Figure 6B). NSUN2-silenced
Sai1 and AF22 cells (siNSUN2) were less efficient in migra-
tion through the membrane compared with control cells,
in particular toward medium containing FGF2 (Figures
6C and 6D). Thus, loss of NSUN2 inhibited FGF2-induced
cell migration of NES cells.
In summary, loss of NSUN2 impairs normal brain devel-
opment by reducing the number of differentiated upper-
layer neurons in the cortical plate. Since loss of NSUN2
also impaired cellular migrations, the delay in neural dif-
ferentiation might rather be caused by the inability of
NSUN2/ cells to efficiently respond to lineage-inducing118 Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017cytokines than by direct interference with the expression
of differentiation genes (Figure 7).DISCUSSION
Loss of function of NSUN2 impairs normal brain develop-
ment and leads to microcephaly in mouse and human
(Blanco et al., 2014; Martinez et al., 2012). Here, we reveal
that the microcephaly phenotype can be explained by a
reduced number of upper-layer neurons in the cerebral cor-
tex. Theprecise timingof self-renewal anddifferentiationof
neural progenitor cells aswell as theirmigration and correct
expansion are essential for normalmammalian brain devel-
opment (Kriegstein and Alvarez-Buylla, 2009). Disturbance
of anyof these processes can lead tomicrocephaly (Manzini
Figure 6. Reduced Migration of Neuroepi-
thelial Stem Cells in the Absence of NSUN2
(A) Western blot for NSUN2 after transfecting
Sai1 or AF22 cells with NSUN2 or scrambled
(Ctr) siRNAi constructs using two different
amounts of transfection reagents (in mL).
(B) Boyden chamber assay to measure
migration in the presence or absence of FGF2.
A total of 10,000 cells were plated.
(C) Quantification of migrated cells at the
indicated time points shown as mean ± SD
(n = 3 wells per time point and condition).
(D) Example image of migrated cells in
the presence of FGF2 after 6 hr. Nuclei are
stained with DAPI. Ctr, cells transfected with
scrambled RNAi.and Walsh, 2011; Thornton and Woods, 2009). Similar to
other tissues in the Nsun2/ mice, the brain develop-
mental deficits were not due to impaired cellular prolifera-
tion (Blanco et al., 2011; Hussain et al., 2013b). On the con-
trary, we found an increase in TBR2-positive intermediate
progenitors in theNsun2/ cortex. The increase in progen-
itors but decrease of SATB2-positive upper-layer neurons
strongly suggested a delay in differentiation.
To understand how NSUN2 and its methylated RNA tar-
gets interfere with neural differentiation pathways, we
identified all NSUN2-dependent 5-methylcytosines in total
RNA of the developing forebrain. In line with our previous
studies in normal skin and skin tumors, we only find a
robust loss of m5C in tRNAs (Blanco et al., 2014, 2016).
The overall lower methylation rate at distinct sites within
cRNAs and ncRNAsmight have several reasons: (1) the sites
could be bisulfite conversion artifacts; (2) the sites are more
difficult to detect due to the lower RNA stability compared
with tRNAs; (3) the low percentage of methylation at
distinct sites might indicate that only a small proportion
of the expressed cellular RNA carried the modification.
Thus, we cannot exclude that the few cRNAs and ncRNAs
carrying NSUN2-dependent m5C sites contribute to the
brain developmental deficits. However, we now demon-
strate that the impaired cellular differentiation is at least
in part dependent on tRNA methylation. Differentiation
of cultured human NES cells was less efficient in the
absence of NSUN2, and the decreased capacity to differen-
tiate was potentiated by angiogenin.
Angiogenin was the first human tumor-derived protein
with in vivo angiogenic activity (Fett et al., 1985). Sincethen angiogenin has been implicated in a wide range of
cellular responses including cell migration, invasion, pro-
liferation, and formation of tubular structures (Gao and
Xu, 2008). Small ncRNAs derived from angiogenin-medi-
ated tRNA cleavage inhibit endothelial cell migration and
tube formation (Li et al., 2016). Deletion of NSUN2 in
induced tRNA cleavage, and reduced migration of human
epidermal cells (Blanco et al., 2016).
Impaired neural migration and defects in the actin cyto-
skeleton are well-known factors contributing to malforma-
tions during the cortical development (Pang et al., 2008).
Reduced expressionofNSUN2 inhumanNES cells impaired
migration toward the chemoattractant FGF2. FGF2 is
widely used to maintain neural progenitors in long-term
culture (Ostenfeld and Svendsen, 2004), is crucial for
normal brain development, and is highly expressed in the
ventricular zone when neural progenitors are formed
(Dono et al., 1998; Vaccarino et al., 1999). Interestingly, in-
jection of FGF2 into the mouse cerebral ventricles at E14 in
utero did not affect the alignment of the cerebral neuronal
layers; however, bothcell number andcell densityof theup-
per layers (II/III) and the lower layers (IV–VI) of the cerebral
cortex were increased (Ohmiya et al., 2001).
In conclusion, our data support a model in which
NSUN2-mediated tRNA methylation is required for effi-
cient migration and differentiation of intermediate pro-
genitors in the ventricular zone toward the upper-layer
neurons. Failure to produce NSUN2 protein during devel-
opment reduces the sensitivity toward growth factors and
decreases the number of upper-layer neurons, and causes
neurodevelopment deficits including microcephaly.Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017 119
Figure 7. Summary of NSUN2 Functions in NES and Progenitor
Cells
Shown are effects on tRNA methylation (blue dots), cell differen-
tiation, and migration, as well as thickness of cortical layers in the
presence (NSUN2-positive) and absence (NSUN2-negative) of
NSUN2. Dotted lines show the reduction of migration and differ-
entiation. Orange dot represents the chemoattractant.EXPERIMENTAL PROCEDURES
Ethics Statements
All studies with human tissue were performed under ethical
approval from the Cambridgeshire Research Ethics Committee
(Reference 96/085) using tissue donated with informed consent
after elective termination of pregnancy. The storage and use of
human tissue were approved by the Human Tissue Authority, UK
(License 12196).
The mice were housed in the Wellcome Trust - Medical Research
Council Cambridge Stem Cell Institute Animal Unit. All mouse
husbandry and experiments were carried out according to the local
ethics committee under the terms of a UK Home Office license
PPL80/2619 and PPL70/7822.
Transgenic Mice
Nsun2/ mice (D014D11) and the MBKW mouse strain
(Nsun2tm1a(EUCOMM)Wtsi) are described in Blanco et al. (2011). The
angiogenin small-molecule inhibitor N65828 (8-amino-5-(40-hy-
droxybiphenyl-4-ylazo)naphthalene-2-sulfonate) was obtained
from the National Cancer Institute (http://dtp.cancer.gov). For
in vivo administration, N65828 (400 mg/mL in PBS [pH.7.4]) was
subcutaneously injected every second day into pregnant Nsun2+/
female mice at a dose of 2.5 mg/kg. Pregnant mice were treated
from E12.5 until E18.5 (Blanco et al., 2014).
Culture and Differentiation of NES Cells
Sai1 NES cells were derived from 6-week-old human embryos and
AF22 neuroepithelial-like stem cells from human induced pluripo-
tent stem cells (Falk et al., 2012; Tailor et al., 2013). The cell lines
were kindly provided by Austin Smith. All cell lines were main-
tained in humidified incubators at 5% CO2 and 37
C. AF22 and
Sai1were grown inDMEM/F12/Glutamaxmedium (Thermo Fisher120 Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017Scientific) supplementedwith B27 (1:50, Thermo Fisher Scientific),
N2 (1:100, Thermo Fisher Scientific), human EGF (10 ng/mL,
Thermo Fisher Scientific), and FGF2 (10 ng/mL, Thermo Fisher Sci-
entific 13256-029). Cells were passaged at ratios no higher than 1:3
to avoid low cell density. Cell dissociation was achieved using
trypsin, which was later neutralized with Defined Trypsin Inhibi-
tor (Thermo Fisher Scientific) and washed thoroughly with fresh
medium. All tissue culture flasks and plates were coated with
poly-L-ornithine (0.1 mg/mL, Sigma) at 37C for 30 min and
with laminin (10 mg/mL, Sigma) at 4C overnight prior to cell seed-
ing. Half of the culture medium of the cells was replaced every day
to prevent spontaneous differentiation.
For the differentiation experiments, cells were seeded at low or
high confluency on day 0 with complete medium containing
FGF2 and EGF. The next day, cells were washed twice with PBS
and cultured with freshmedium lacking the FGF2 and EGF growth
factors. Every 2 days, half of the volume of the culturemediumwas
replaced. At least twice a week, laminin (10 mg/mL) was added to
the medium.siRNA Transfection of NES Cells
AF22 and Sai1 cells were transfected with a negative control
siRNA (Qiagen) or Nsun2 siRNA (SI02655548; Qiagen) at a final
concentration of 20 nM. For confirmation of the Nsun2 siRNA
results, cells were transfected with a pool of different siRNA con-
structs: SI00300230, SI04205411, SI04224668, SI04308640, and
SI04325874 (Qiagen). The transfection was performed using the
DharmaFECT (Dharmacon) according to themanufacturer’s proto-
col using 0.75 or 1.5 mL of DharmaFECT transfection reagent. The
transfection solutionwas added to the cells for 6–12 hr, after which
the medium was changed.
For knockdown of Nsun2 in differentiated cells, NES cells were
subjected to several cycles of transfection followed by 1 day of me-
dium change and recovery. Transfections were performed at
days 2, 0, 2, and 4 of the differentiation protocol. For instance,
the first transfectionwas performed 24 hr after passaging (differen-
tiation day 2) and the medium was changed the following day.
One day later, the cells were retransfected and the medium was
changed to differentiation medium (day 0). When samples were
collected at day 4, the last transfection was at day 2 andwhen sam-
ples were collected at day 8, the last transfection was at day 4.Western Blot and Real-Time qPCR Analyses
Cells were lysed in RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM
NaCl,1%NP-40, 0.5%sodiumdeoxycholate, and0.1%SDS). Imme-
diately beforeuse, one tablet of theCOMPLETEMini EDTA-freepro-
tease inhibitor (Roche)was added.Mousebrainswere lysedbyeither
tissue homogenization or sonication. Lysates were incubated on
ice for 20 min and cleared from cell debris by centrifugation at
16,000 3 g for 20 min. Protein lysates were quantified using the
Coomassie Protein Assay Kit (Thermo Scientific). Proteins were
transferred onto Hybond-C nitrocellulose membranes (GE Health-
care). Membranes were blocked for 1 hr with 5% skim milk in
0.1% TBS-T (Tris-buffered saline with 0.1% Tween 20) buffer and
incubated overnight at 4C with the primary antibody diluted in
the same blocking solution (1:2,000 NSUN2 [hmetA]; 1:50,000
a-tubulin [ab4074; Abcam]; 1:400 TUBB31 [MAB1195; R&D
Systems]; 1:500 GFAB [M0761; Dako]; 1:1,000 Sox2 [ab97959; Ab-
cam]; 1:1,000 Nestin [SC21248; Santa Cruz Biotechnology]). The
following day the membranes were washed and incubated for 1 hr
at room temperature with the appropriate horseradish peroxidase
(HRP)-conjugated antibody diluted in the blocking buffer. Three
more washes were performed prior to incubation with the ECL
Prime Western Blotting Detection Reagent (GE Healthcare) for
detection of HRP-mediated chemiluminescence.
Total RNA from cultured cells or mouse brains was extracted us-
ing TRIzol following the manufacturer’s instructions (Thermo
Fisher Scientific). The Superscript III Reverse Transcriptase kit
(Thermo Fisher Scientific) was used to generate cDNA from total
RNA, according to the manufacturer’s instructions. Real-time
PCR amplification and analysis was conducted using either the
7900HT Real-Time PCR System (Applied Biosystems) or theQuant-
Studio 12K Flex Real-Time PCR System (Applied Biosystems). The
fast amplification protocolwas performedwith pre-designed probe
sets (NSUN2: Hs00214829_m1; TUBB3/TUJ1: Hs00801390_s1)
and TaqMan Fast Universal PCR Master Mix (23) (Applied Bio-
systems). GAPDH was used as endogenous control (4352934E;
Applied Biosystems).Immunofluorescence of Tissue and Cells
Frozen gelatin/sucrose brain sections were incubated in PBS at
37C for 30 min to remove gelatin. Antigen retrieval was per-
formed by incubating the samples with boiling 0.01M sodium cit-
rate (pH 6.0) for 15 min, after which the samples were allowed to
cool down and were washed twice with TBS. The slides were
then incubated with blocking solution containing 5% donkey
serum in TBS-T for 1 hr at room temperature. Primary antibodies
were diluted in blocking solution as follows: 1:200 Sox1 (AF3369;
R&D); 1:200 Nsun2 (hmetA); 1:500 Nestin MAB1259; R&D);
1:500 Sox2 (ab75485; Abcam); 1:400 TUBB3 (MAB1195; R&D);
1:400 Pax6 (AB2237; Millipore); 1:500 Tbr1 (ab31940; Abcam);
1:300 Tbr2 (ab23345; Abcam); 1:200 Ctip2 (ab18465; Abcam);
1:500 Satb2 (ab51502; Abcam). These antibodies were incubated
overnight at 4C. The slides were then washed three times with
TBS and incubated with secondary antibodies diluted in the block-
ing solution (1:500) for 1 hr at room temperature. Tissues were
washed thrice with TBS and incubated with DAPI (1:10,000) in
PBS. Tissues were mounted onto slides using Mowiol.
Neuroepithelial cell lineswere seededontoglass coverslips coated
with poly-L-ornithine and laminin. Cells were fixed with 4% para-
formaldehyde (PFA) for 10 min, washed three times with PBS, and
permeabilized with 0.2% Triton X-100 in PBS for 10 min, followed
by a 1-hr incubation step with blocking buffer containing 5%
donkey serum(Sigma) inPBS-T (PBSwith0.1%Tween). Primary an-
tibodies diluted in the blocking buffer were then added to the cells
for overnight incubation at 4C. Cells were washed three times
with PBS-T and then incubated for 1 hr at room temperature with
blocking buffer containing fluorophore-conjugated secondary an-
tibodies (1:500) and DAPI for 1 hr. After three more washes with
PBS-T, the cells were mounted using Mowiol.Image Acquisition and Quantification
All fluorescence images were acquired using a Leica SP5 confocal
microscope. For quantifications, images of an area of 500 mm ofcortex were taken. Bright-field images were acquired using an
Olympus IX50 microscope. Quantifications were performed using
Volocity software. Cortical marker quantifications were performed
using Cell Profiler. All images were edited using ImageJ/Fiji.
Flow Cytometry
NES cells were grown in medium with or without growth factors
and treated with siRNA for NSUN2 and/or angiogenin (1 mg/mL;
R&D, 265-AN-250/CF). Five biological replicates were collected
for each condition. Cells were collected with Tryple Express and
spun down. The cell pellet was washed and resuspended in 2%
BSA in PBS. For cell differentiation analysis, antibody dilutions
were prepared in 2% BSA in PBS. The following antibody dilu-
tions were used: anti-NCAM (PE-conjugated, Santa Cruz, sc-106
PE, 1:25); anti-CD24 (fluorescein isothiocyanate [FITC]-conju-
gated, Becton Dickinson, 560992, 1:50). Cells were mixed with
antibodies and incubated on ice for 30 min. After washing, the
cells were resuspended in 500 mL of PBS for flow cytometry anal-
ysis. The flow cytometry analysis was performed in an LSRFor-
tessa flow cytometer (BD). Controls for gating were unstained
cells of the same condition (days 0, 4, and 8). Cells stained with
each individual fluorophore (i.e., only PE-conjugated anti-
NCAM; only FITC-conjugated anti-CD24) were used to compen-
sate for overlap between the emission waves of the two fluoro-
phores. The data were analyzed using FlowJo software (www.
flowjo.com).
Cell Migration Assay
The transwell inserts (8 mm, BD Biosciences) were placed into
24-well plates and coated from both sides with polyornithine
for 2 hr at 37C and with laminin overnight at 4C. The inserts
were washed with PBS and placed inside a new 24-well plate con-
taining 500 mL of medium/well with FGF2 (10 mg/mL). AF22 and
Sai1 cells were trypsinized, counted, and resuspended in appro-
priate medium (no growth factors or FGF2); 10,000 cells were
plated per insert. Cells were incubated in a time course from 1
to 20 hr, after which the inserts were washed once with PBS, fixed
with 4% PFA for 10 min, and washed three more times with
PBS. Cells were stained with DAPI. Non-migrated cells were
scratched off from the upper side of the membrane with a cotton
bud, with PBS washes in between. Migrated DAPI+ cells on the
bottom side of the membrane were imaged with a colony-
scan microscope. Cells were then quantified with the software
CellProfiler.
Generation of RNA Bisulfite-Converted and tRNA
Sequencing Libraries
For RNA extraction frommouse embryonic brains (E18.5; four bio-
logical replicates per genotype) the brains were snap frozen in
liquid N2 directly after dissection, and kept on dry ice and homog-
enized in 1 mL of TRIzol. TRIzol was then mixed with 0.2 volume
of chloroform (200 mL), centrifuged, and the upper phase was
mixed with 0.5 volume of isopropanol (500 mL). The following
stepswere performed according to themanufacturer’s instructions.
Total RNA was treated with TURBO DNAse (Thermo Fisher Scien-
tific) according to the manufacturer’s instructions and subjected
to an acidic phenol/chloroform extraction. The RNA wasStem Cell Reports j Vol. 8 j 112–124 j January 10, 2017 121
resuspended in H2O and treated with the RiboZero Magnetic Kit
(Epicentre, MRZH11124) to remove rRNA. At least 2 mg of RNA
was used for the bisulfite library preparation.
The RNA was bisulfite-converted as described previously
(Blanco et al., 2014). About 2 mg of RNA was diluted in 70 mL
of 40% sodium bisulfite (pH 5.0) and DNA protection buffer
(Imprint DNA Modification Kit, Sigma). The reaction mixture
was incubated in a thermocycler for four cycles of 5 min at
70C followed by 1 hr at 60C. The reaction mix was then loaded
onto Micro Bio-spin6 chromatography columns (Bio-Rad) to re-
move salts from solution. Total RNA was desulfonated by adding
an equal volume of 1 M Tris (pH 9.0) to the reaction mixture and
incubating it at 37C for 1 hr. The RNA was then purified by
ethanol precipitation.
The bisulfite-converted RNAwas assessed for quality and concen-
tration using a Bioanalyzer 2100 RNA nanochip (Agilent). For the
generation of bisulfite sequencing libraries, at least 120 ng of bisul-
fite-converted RNA was used. Bisulfite sequencing libraries were
prepared using the TruSeq Small RNA Preparation Kit (Illumina),
mostly according to the manufacturer’s instructions with the
exception of the size-selection step before hybridization (not per-
formed due to sample fragmentation). Firstly, 20,30-cyclic phos-
phate and 50-hydroxyl termini produced during the bisulfite/
desulfonation reaction were end-repaired using T4 PNK and Sper-
midine (New England Biolabs). RNA adapters suitable for Illumina
sequencing were then ligated and the RNAwas reverse-transcribed
at 50C for 1 hr with SuperScript III and 1 mM of each dNTP
(SuperScript III cDNA synthesis kit, Thermo Fisher Scientific).
The final step of library preparationwas an 18-cycle PCR amplifica-
tion, with no further size-selection steps.
The tRNA sequencing libraries were generated from E13.5 and
E18.5 embryonic mouse brains. Four independent biological repli-
cates per genotype were generated. Total RNA was extracted and
treated with DNAse and Ribozero. The remaining RNA fraction
was size-selected with the MirVana Isolation Kit (Invitrogen) for
20- to 200-base-paired RNAs, following themanufacturer’s instruc-
tions. The RNAs were deaminoacylated in 0.1 M Tris-HCl (pH 9.0)
and 1 mM EDTA for 30 min at 37C. Small RNA libraries were pre-
pared using TruSeq Small RNA Preparation Kit (Illumina), accord-
ing to the manufacturer’s instructions. After adapter ligation and
reverse transcription steps the cDNA was subjected to 16 cycles
of PCR amplification with Phusion DNA polymerase (Thermo
Fisher Scientific) and size-selected (140–210 bp) before sequencing.
All samples were multiplexed and sequenced in a HiSeq platform
(Illumina).Next-Generation Sequence Data Analyses
For all data analyses, FastQC was used for the initial assessment
of the quality and basic processing of the reads (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc). Sequencing
adapters were trimmed from the 50 and the 30 ends of the reads
using cutadapt (v1.4.2; https://pypi.python.org/pypi/cutadapt/
1.4.2).RNA Bisulfite Sequencing Analysis
Sequences for ENSEMBL transcripts and tRNAs were extracted in
FASTA format to determine RNA methylation levels in the mouse122 Stem Cell Reports j Vol. 8 j 112–124 j January 10, 2017brain samples. All transcript isoformswere considered, and in addi-
tion the longest gene at full length including introns was retained
as a representative sequence to identify RNA methylation sites in
introns. Cs were converted to Ts in the reference transcript se-
quences, and in the processed bisulfite sequencing reads. Align-
ment of converted bisulfite sequencing reads against converted
transcript sequences were performed using bowtie (version 1.1.1;
bowtie-bio.sourceforge.net; options ‘‘–m 500 –v 2 –a –best –strata’’).
Following alignments, the reads that aligned in sense direction
were obtained, and the original transcript sequences and reads
were used to compile RNA methylation (C/(C + T)) levels consid-
ering only cytosines with at least 53 coverage. Heatmaps display-
ing either C or T in the aligned reads at each cytosine positionwere
generated using custom PERL scripts and matrix2png (www.chibi.
ubc.ca/matrix2png/) for visualization. Cytosine positions on the
heatmaps were reported relative to the annotated transcriptional
start sites of the transcripts.
The conversion rate of unmethylated cytosines to uracil in
tRNAs, ncRNA, and coding RNA is the subtraction of the pooled
methylation value from 100. Only sites that were covered by a
minimum of 10 reads (average over four replicates) in wild-type
and Nsun2/ brains were included in the analysis. The pooled
methylation value of each cytosine was estimated using four bio-
logical replicates per genotype.
tRNA Sequencing Data Analysis
The abundance of tRNA fragments was determined as described
previously (Blanco et al., 2014). Adapter-trimmed tRNA
sequencing reads (>20 nt and <200 nt in length) were mapped to
the mouse reference genome (GRCm38/mm10) using bowtie
(version 1.1.1; bowtie-bio.sourceforge.net; options ‘‘-m1 –v2 –a
–best –strata’’) considering only reads that map uniquely to the
genome. To account for the polymerization of CCA 30 ends onto
mature tRNAs, we trimmed the remaining unmapped reads of
CCA[CCA] ends and realigned using the same options. Annota-
tionswere conducted based on tRNA genes predicted for themouse
reference genome (GRCm38/mm10) and downloaded from
GtRNAdb (http://lowelab.ucsc.edu/GtRNAdb). Reads that ex-
ceeded the annotated tRNA gene start or end by more than 10%
were discarded. All distinct reads, which were shorter than 90%
of the annotated tRNA gene length, were considered as tRNA
fragments.
Statistical Analyses
Unless indicated otherwise, the statistical analysis was assessed us-
ing an unpaired Student’s t test using a minimum of three repli-
cates per condition.
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